State Of Alaska, Department Of Revenue Gilead Sciences, Inc. Transaction History

State Of Alaska, Department Of Revenue

$8.78 Billion
Q1 2024

A detailed history of State Of Alaska, Department Of Revenue transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 229,826 shares of GILD stock, worth $15.3 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

229,826

Previous 248,301 7.44%

Holding current value

$15.3 Million

Previous $20.1 Million 16.31%

% of portfolio

0.19%

Previous 0.24%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$71.58 - $87.29 $1.32 Million - $1.61 Million	-18,475 Reduced 7.44%	229,826 $16.8 Million
Q4 2023 Jan 19, 2024	SELL	$73.27 - $83.09 $465,264 - $527,621	-6,350 Reduced 2.49%	248,301 $20.1 Million
Q3 2023 Oct 16, 2023	BUY	$73.94 - $80.67 $2.39 Million - $2.61 Million	32,355 Added 14.55%	254,651 $19.1 Million
Q2 2023 Jul 24, 2023	SELL	$76.01 - $86.7 $6.29 Million - $7.17 Million	-82,700 Reduced 27.12%	222,296 $17.1 Million
Q1 2023 Apr 17, 2023	SELL	$77.31 - $88.08 $266,719 - $303,876	-3,450 Reduced 1.12%	304,996 $25.3 Million

Q4 2022 Jan 11, 2023	SELL	$62.32 - $89.47 $290,099 - $416,482	-4,655 Reduced 1.49%	308,446 $26.5 Million
Q3 2022 Oct 20, 2022	SELL	$59.54 - $68.01 $1.39 Million - $1.59 Million	-23,330 Reduced 6.93%	313,101 $19.3 Million
Q2 2022 Jul 08, 2022	SELL	$57.72 - $65.01 $6.83 Million - $7.69 Million	-118,342 Reduced 26.02%	336,431 $20.8 Million
Q1 2022 Apr 14, 2022	SELL	$57.92 - $72.58 $2.26 Million - $2.83 Million	-38,998 Reduced 7.9%	454,773 $27 Million
Q4 2021 Jan 12, 2022	SELL	$64.88 - $73.64 $2.59 Million - $2.94 Million	-39,970 Reduced 7.49%	493,771 $35.9 Million
Q3 2021 Oct 07, 2021	SELL	$67.69 - $73.03 $1.92 Million - $2.07 Million	-28,301 Reduced 5.04%	533,741 $37.3 Million
Q2 2021 Jul 12, 2021	BUY	$63.47 - $69.35 $1.29 Million - $1.41 Million	20,272 Added 3.74%	562,042 $38.7 Million
Q1 2021 Apr 09, 2021	SELL	$60.0 - $68.46 $2.54 Million - $2.89 Million	-42,279 Reduced 7.24%	541,770 $35 Million
Q4 2020 Jan 08, 2021	SELL	$56.65 - $64.55 $9.35 Million - $10.7 Million	-165,058 Reduced 22.03%	584,049 $34 Million
Q3 2020 Oct 05, 2020	BUY	$62.1 - $78.08 $15.7 Million - $19.8 Million	253,419 Added 51.12%	749,107 $47.3 Million
Q2 2020 Jul 06, 2020	BUY	$72.34 - $84.0 $16.8 Million - $19.5 Million	231,703 Added 87.77%	495,688 $38.1 Million
Q1 2020 Apr 06, 2020	BUY	$62.63 - $80.22 $745,798 - $955,259	11,908 Added 4.72%	263,985 $19.7 Million
Q4 2019 Jan 07, 2020	SELL	$61.62 - $67.78 $1.24 Million - $1.37 Million	-20,176 Reduced 7.41%	252,077 $16.4 Million
Q3 2019 Oct 02, 2019	BUY	$62.51 - $69.0 $5.4 Million - $5.96 Million	86,311 Added 46.42%	272,253 $17.3 Million
Q2 2019 Jul 23, 2019	BUY	$61.87 - $69.38 $613,255 - $687,694	9,912 Added 5.63%	185,942 $12.6 Million
Q1 2019 Apr 09, 2019	SELL	$62.53 - $70.05 $1.03 Million - $1.15 Million	-16,465 Reduced 8.55%	176,030 $11.4 Million
Q4 2018 Jan 10, 2019	BUY	$60.54 - $79.0 $134,277 - $175,222	2,218 Added 1.17%	192,495 $12 Million
Q3 2018 Oct 09, 2018	BUY	$71.28 - $78.92 $112,551 - $124,614	1,579 Added 0.84%	190,277 $14.7 Million
Q2 2018 Jul 10, 2018	BUY	$64.88 - $75.68 $2.43 Million - $2.83 Million	37,380 Added 24.7%	188,698 $13.4 Million
Q1 2018 Apr 19, 2018	BUY	$72.84 - $88.8 $1.66 Million - $2.03 Million	22,820 Added 17.76%	151,318 $11.4 Million
Q4 2017 Jan 19, 2018	BUY	$71.15 - $83.52 $8.64 Million - $10.1 Million	121,428 Added 1717.51%	128,498 $9.2 Million
Q3 2017 Oct 16, 2017	BUY	$72.11 - $85.47 $509,817 - $604,272	7,070	7,070 $572,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.5B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Account

State Of Alaska, Department Of Revenue Gilead Sciences, Inc. Transaction History